CLEARWATER, Fla. -- In a move originally announced in 2002 as a consolidation effort, officials at Maxxim Medical will begin phasing out production at their Richmond, Va., facility.
"During the past 18 months, Maxxim Medical has made significant strides in productivity improvement and process enhancements; advances that will now allow us to consolidate several of our production sites," says Thomas R. Cochill, president and CEO. "Process improvements and automated assembly upgrades to the Clearwater facility have made this move possible as well as beneficial."
The closing cannot come as a surprise to employees -- company officials have recently filed for Chapter 11 reorganization.
"This plan long predates our filing and reflects normal, sound business planning as part of our ongoing business management and improvement processes," he says.
For more information, visit: www.maxximmedical.com.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.